Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
about
EZH2 in normal hematopoiesis and hematological malignanciesThe epigenetic basis of diffuse large B-cell lymphomaSuper-enhancers: Asset management in immune cell genomesChromatin signatures of cancerNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewBET inhibitors in the treatment of hematologic malignancies: current insights and future prospectsEpigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?The Role of Histone Acetyltransferases in Normal and Malignant HematopoiesisThe mechanisms behind the therapeutic activity of BET bromodomain inhibitionConvergent transcription at intragenic super-enhancers targets AID-initiated genomic instabilityFunctions of BET proteins in erythroid gene expressionTargeting BET bromodomains for cancer treatmentdbSUPER: a database of super-enhancers in mouse and human genomeDRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradationIdentification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression dataBRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cellsThe "histone mimicry" by pathogens.Role of MYC in B Cell Lymphomagenesis.Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits.The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsIdentification and characterization of essential genes in the human genome.BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin.Genetic alterations of the cohesin complex genes in myeloid malignancies.BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.Therapeutic strategies to inhibit MYCTargeting transcription regulation in cancer with a covalent CDK7 inhibitorCDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorEnhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.Resolving the daratumumab interference with blood compatibility testing.Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape.Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.CDK7-dependent transcriptional addiction in triple-negative breast cancer.SEA: a super-enhancer archive.
P2860
Q26779821-010729B8-8D84-482C-9AA9-1E3973FD8CFFQ26852288-63079259-A784-4F95-BA4E-7E26BE5BC700Q26861020-633C7845-D2C3-47C7-9CEA-A30E38557354Q27024162-E1303D45-7BAC-444C-AB8B-1CDB0B5673D2Q27304386-2A1C8D3F-425F-4759-BFFF-FC94E2EE9544Q28066765-1A3B18AD-820F-4DB4-BEC8-F4A8A1336369Q28076548-3EBA477D-6D22-4CFB-98D4-FF2CCF013EF0Q28088295-D7B01242-4191-49EB-9E01-ED1D834032F1Q28241504-FFE62299-D3E3-417C-874D-C4AE0BDB20AAQ28253489-1F991040-A1E7-4E97-85C1-6E6E45341EFBQ28257378-32FF5989-8B9F-46D3-8B2C-3C882BEB4266Q28263519-6057B57F-0304-43CA-BC2F-340D35AA6559Q28603137-43EF6EE7-D029-417B-ACE6-8DC3441E9501Q28830958-DE1DA0E8-D836-4F28-8688-D6DAA91A7595Q31095260-13B5360C-B784-48A4-AA16-51DB247C2C28Q33557475-66754203-F384-4292-8464-92B5F15AB352Q33606391-900FAAC0-B117-4F82-86A9-D8A6C41567D8Q33608499-65998FBC-B84D-4DD9-B405-89CD72499BCAQ33671971-E4F6CC15-9B12-4F69-858A-489457A0AA8BQ33806005-6BC8BB2D-7429-47EC-B492-B65F4B451695Q33877534-C5CEDF4A-5612-4C2E-9C39-0F2D58237BFBQ33987601-5D54450A-6037-487F-A97D-4B78E4DFB400Q34025327-B7D097AB-73B7-4B4F-B88B-2B98502D2A85Q34045164-DEEC6762-021F-4A45-B877-DBB9902EE615Q34046783-CD7F5411-B744-4036-BECF-AFAA1E749C7CQ34170374-574B39B3-C866-40F7-8C0C-E8DDFCD43744Q34289202-D3FF377E-FB20-460A-95C8-ED5EC4B17DECQ34355349-BBD99571-62B5-4451-92AF-32E29428609CQ34429918-38A048A6-741D-44C6-BFD5-2FF2C3225E82Q34449062-1630EFC4-427B-4D02-BCF7-348E150C222CQ34452854-8F5D8EF6-8B2C-43B1-B25C-F67FAF255B3DQ34458974-7D12CD86-D357-4349-8A5F-9B299E85E450Q34466828-CE3ED20C-CE93-42F3-B966-4EA37927367FQ34468271-F860F24E-2F78-4C68-BB6C-EACC797FC958Q34479551-3C74AD91-3967-4175-95EB-A593F2D2BD8CQ34489749-0C9F6285-6805-4AF7-BEFB-B302BBC2EE8AQ34492346-F0124460-CC7A-4833-A93F-5684B470BA45Q34494007-080C9DF0-E294-4A8F-B27C-9D2D04DF1D6CQ34495729-CF4446BC-F76D-48F2-8243-AC8E413596E3Q34502036-C22C2439-E736-4159-936B-C13A0E291E44
P2860
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Discovery and characterization ...... diffuse large B cell lymphoma.
@ast
Discovery and characterization ...... diffuse large B cell lymphoma.
@en
type
label
Discovery and characterization ...... diffuse large B cell lymphoma.
@ast
Discovery and characterization ...... diffuse large B cell lymphoma.
@en
prefLabel
Discovery and characterization ...... diffuse large B cell lymphoma.
@ast
Discovery and characterization ...... diffuse large B cell lymphoma.
@en
P2093
P2860
P50
P1433
P1476
Discovery and characterization ...... diffuse large B cell lymphoma
@en
P2093
Bjoern Chapuy
Charles Y Lin
Elaine Reichert
Heather H Sun
James E Bradner
John G Doench
Kelly T Yeda
Margaret A Shipp
Margaretha G M Roemer
P2860
P304
P356
10.1016/J.CCR.2013.11.003
P577
2013-12-01T00:00:00Z